Establishments and authorised organisations shall implement a procedure for the recall of tissues or their derivatives or cell therapy preparations in accordance with the rules of good practice provided for in Article L. 1245-6 and including a description of the responsibilities and measures to be taken, including for storage provided under the conditions provided for in Article R. 1243-3-1. The responsible person mentioned in article R. 1243-12 undertakes and coordinates the necessary actions.
The responsible person notifies the Director General of the Agence nationale de sécurité du médicament et des produits de santé of any recall measure. It shall send a copy of this notification to the Director General of the Agence de la biomédecine.